Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00949715 · ClinicalTrials.gov registry record · NA
Optimize RV Follow-up Selective Site Pacing Clinical Trial
A NA study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- NA
- Development phase
- 67
- Enrollment target
NCT00949715 is a NA study that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 67 participants.
The verdict
NCT00949715, a NA study, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
Study Summary
The purpose of the Optimize RV Follow-Up study is to determine the long-term effect of selective site pacing. Selective site pacing refers to which area of the right ventricle the lead is placed. The goal of selective site pacing is to improve how the heart contracts when paced.
Interventions
- DEVICE Medtronic or Vitatron Dual-Chamber Pacemaker
- DEVICE Medtronic SelectSecure 3830 Lead
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2009-09 |
| Est. Completion | 2011-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00949715
The ClinicalTrials.gov registry entry for NCT00949715 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Medtronic or Vitatron Dual-Chamber Pacemaker is the first listed.
NCT00949715 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00949715 about?
NCT00949715 is a clinical study titled "Optimize RV Follow-up Selective Site Pacing Clinical Trial". The purpose of the Optimize RV Follow-Up study is to determine the long-term effect of selective site pacing. Selective site pacing refers to which area of the right ventricle the lead is placed. The goal of selective site pacing is to improve how the heart contracts when paced.
What is the current status of trial NCT00949715?
This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2009-09. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00949715?
The interventions under investigation include: Medtronic or Vitatron Dual-Chamber Pacemaker (DEVICE), Medtronic SelectSecure 3830 Lead (DEVICE).
Who is sponsoring clinical trial NCT00949715?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.